Terms: = Lung cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA
897 results:
1. Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer.
Li Y; Sharma A; Schmidt-Wolf IGH
Mol Cancer; 2024 Apr; 23(1):80. PubMed ID: 38659003
[TBL] [Abstract] [Full Text] [Related]
2. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
van Kooten JP; Dietz MV; Dubbink HJ; Verhoef C; Aerts JGJV; Madsen EVE; von der Thüsen JH
Clin Exp Med; 2024 Apr; 24(1):80. PubMed ID: 38642130
[TBL] [Abstract] [Full Text] [Related]
3. Association of the Advanced lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
Jiang H; Li B; Wu M; Wang Q; Li Y
BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
[TBL] [Abstract] [Full Text] [Related]
4. Outcome differences by sex in oncology clinical trials.
Kammula AV; Schäffer AA; Rajagopal PS; Kurzrock R; Ruppin E
Nat Commun; 2024 Mar; 15(1):2608. PubMed ID: 38521835
[TBL] [Abstract] [Full Text] [Related]
5. Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
[TBL] [Abstract] [Full Text] [Related]
6. Multi-modal deep learning methods for classification of chest diseases using different medical imaging and cough sounds.
Malik H; Anees T
PLoS One; 2024; 19(3):e0296352. PubMed ID: 38470893
[TBL] [Abstract] [Full Text] [Related]
7. The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis.
Guo H; Lin H
BMC Surg; 2024 Mar; 24(1):79. PubMed ID: 38438944
[TBL] [Abstract] [Full Text] [Related]
8. Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic lung cancer Therapy.
Wang MM; Deng DP; Zhou AM; Su Y; Yu ZH; Liu HK; Su Z
Inorg Chem; 2024 Mar; 63(10):4758-4769. PubMed ID: 38408314
[TBL] [Abstract] [Full Text] [Related]
9. Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs.
Gu Z; Huang P; Zhao J; Luo C; Liao L; Liu A; Huang L
Int J Cancer; 2024 Jun; 154(11):1979-1986. PubMed ID: 38353428
[TBL] [Abstract] [Full Text] [Related]
10. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Besse B; Pons-Tostivint E; Park K; Hartl S; Forde PM; Hochmair MJ; Awad MM; Thomas M; Goss G; Wheatley-Price P; Shepherd FA; Florescu M; Cheema P; Chu QSC; Kim SW; Morgensztern D; Johnson ML; Cousin S; Kim DW; Moskovitz MT; Vicente D; Aronson B; Hobson R; Ambrose HJ; Khosla S; Reddy A; Russell DL; Keddar MR; Conway JP; Barrett JC; Dean E; Kumar R; Dressman M; Jewsbury PJ; Iyer S; Barry ST; Cosaert J; Heymach JV
Nat Med; 2024 Mar; 30(3):716-729. PubMed ID: 38351187
[TBL] [Abstract] [Full Text] [Related]
11. Cardiovascular health, sleeping duration, and risk of mortality in current and former smokers.
Yu B; Sun Y; Yu Y; Yu Y; Wang Y; Wang B; Tan X; Wang Y; Lu Y; Wang N
Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1257-1266. PubMed ID: 38320950
[TBL] [Abstract] [Full Text] [Related]
12. [TRIP13 Enhances Radioresistance of lung Adenocarcinoma Cells
through the Homologous Recombination Pathway].
Ge S; Gu R; Yang X; Xu C; Wang S; Zhu G
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):1-12. PubMed ID: 38296621
[TBL] [Abstract] [Full Text] [Related]
13. Cinobufotalin effect and mechanism on serum MMP-2, MMP-9, Beclin1, LC3-II in advanced NSCLC patients.
Yang L; Bai B; Chen H; Li T; Wang M; Zhu X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):58-62. PubMed ID: 38279494
[TBL] [Abstract] [Full Text] [Related]
14. Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors.
Li Q; Patrick MT; Sreeskandarajan S; Kang J; Kahlenberg JM; Gudjonsson JE; He Z; Tsoi LC
Front Immunol; 2023; 14():1309549. PubMed ID: 38259463
[TBL] [Abstract] [Full Text] [Related]
15. Impact of Pleural Lavage Cytology Positivity on Early Recurrence After Surgery for Non-Small Cell lung cancer.
Recuero Díaz JL; Gatius Caldero S; Rosado Rodríguez J; Caamaño Villaverde V; Gómez de Antonio D; Tejerina E; Sánchez Moreno L; Martino González M; Moldes Rodríguez M; Abdulkader Nallib I; Ramírez Gil E; Amat Villegas I; Genovés Crespo M; García Ángel R; Sampedro Salinas C; Figueroa Almánzar S; Compañ Quilis A; Saumench Perramon R; González Pont G; Royo Crespo Í; Gambó Grasa P; García Fernández JL; Jiménez Heffernan JA; Cerón Navarro J; Prieto Rodríguez M; Porcel JM
Arch Bronconeumol; 2024 Mar; 60(3):133-142. PubMed ID: 38238188
[TBL] [Abstract] [Full Text] [Related]
16. Adult Pulmonary Blastoma: A Case Report with Spectrum of Rare Manifestations.
Parkhi M; Ahuja N; Kumar D; Basher RK; Singh N; Singh H; Bal A
Turk Patoloji Derg; 2024; 40(1):63-68. PubMed ID: 38235566
[TBL] [Abstract] [Full Text] [Related]
17. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Value of the Glasgow Prognostic Score in Non-Small Cell lung cancer Patients Receiving Immunotherapy: A Meta-Analysis.
Wang H; Yang R; Cheng C; Wang S; Liu D; Li W
Nutr Cancer; 2024; 76(2):187-195. PubMed ID: 38140926
[TBL] [Abstract] [Full Text] [Related]
19. CRISPR Screen of Druggable Targets in Small Cell lung cancer Identified atm Inhibitor (AZD1390) as a Radiosensitizer.
Ran X; Wu BX; Shi M; Song L; Nixon K; Philip V; He HH; Tsao MS; Lok BH
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1308-1314. PubMed ID: 38104868
[TBL] [Abstract] [Full Text] [Related]
20. The enrichment of Fanconi anemia/homologous recombination pathway aberrations in atm/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis.
Wei W; Shi F; Xu Y; Jiao Y; Zhang Y; Ou Q; Wu X; Yang L; Lai J
J Transl Med; 2023 Dec; 21(1):874. PubMed ID: 38041093
[TBL] [Abstract] [Full Text] [Related]
[Next]
